BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harding DJ, Perera MTP, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21(22): 6769-6784 [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Elkrief L, Payancé A, Plessier A, d’Alteroche L, Ronot M, Paradis V, Valla D, Rautou P. Management of splanchnic vein thrombosis. JHEP Reports 2023. [DOI: 10.1016/j.jhepr.2022.100667] [Reference Citation Analysis]
2 La Mura V, Bitto N, Tripodi A. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges. Expert Rev Hematol 2022;15:1031-44. [PMID: 36342412 DOI: 10.1080/17474086.2022.2144217] [Reference Citation Analysis]
3 Yang M, Luo P, Zhang F, Xu K, Feng R, Xu P. Large-scale correlation analysis of deep venous thrombosis and gut microbiota. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1025918] [Reference Citation Analysis]
4 Konanur M, Reynolds C, Shropshire E, Lerebours R, Wildman-Tobriner B, Allen B, Jaffe T, Erkanli A, Bashir M. Clinical and imaging predictors of the natural course of bland portal vein thrombus in cirrhotic patients. Abdom Radiol (NY) 2022;47:3724-32. [PMID: 35943518 DOI: 10.1007/s00261-022-03626-x] [Reference Citation Analysis]
5 Ye Z, Huang Q, She Y, Hu Y, Wu M, Qin K, Li L, Zhang C, Zuo X, Wei A, Mao D, Ye Q. A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy. Front Med (Lausanne) 2022;9:920062. [PMID: 36314011 DOI: 10.3389/fmed.2022.920062] [Reference Citation Analysis]
6 Guo D, Fan L, Le Q, Huang C. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis. Front Pharmacol 2022;13:968988. [DOI: 10.3389/fphar.2022.968988] [Reference Citation Analysis]
7 Gravetz A. Portal vein-variceal anastomosis for portal vein inflow reconstruction in orthotopic liver transplantation: A case report and review of literature. World J Transplant 2022; 12(7): 204-210 [DOI: 10.5500/wjt.v12.i7.204] [Reference Citation Analysis]
8 Ferral H. Diagnosis and Management of Acute and Chronic Portomesenteric Venous Thrombosis. Digestive Disease Interventions 2022;06:113-120. [DOI: 10.1055/s-0042-1745858] [Reference Citation Analysis]
9 Durán M, Hann A, Lembach H, Nutu A, Clarke G, Patel I, Sneiders D, Hartog H, Mirza DF, Perera MTPR. Normothermic Machine Perfusion as a Tool for Safe Transplantation of High-Risk Recipients. Transplantology 2022;3:169-83. [DOI: 10.3390/transplantology3020018] [Reference Citation Analysis]
10 Prajapati UK, Kansal A, Raj Gaurab A, Kumar Gupta P, Jadi S, Subba M. THE STUDY OF PORTAL VEIN THROMBOSIS PATIENTS WITH CHRONIC LIVER DISEASE. ijsr 2022. [DOI: 10.36106/ijsr/6100414] [Reference Citation Analysis]
11 Talwar A, Varghese J, Knight GM, Katariya N, Caicedo J, Dietch Z, Borja‐cacho D, Ladner D, Christopher D, Baker T, Abecassis M, Mouli S, Desai K, Riaz A, Thornburg B, Salem R. Preoperative portal vein recanalization–transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation. Hepatology Communications. [DOI: 10.1002/hep4.1914] [Reference Citation Analysis]
12 Aziz AA, Yang D, Naeem M, Christmas D. Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices. Cureus 2022. [DOI: 10.7759/cureus.21150] [Reference Citation Analysis]
13 . Vascular Disorders. Non-Neoplastic Diseases of the Liver 2022. [DOI: 10.55418/9781933477183-12] [Reference Citation Analysis]
14 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. J Clin Exp Hepatol 2022;12:965-79. [PMID: 35677518 DOI: 10.1016/j.jceh.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Armocida E, Masciangelo G, Bussolati O. The last battle of Alessandro Farnese (1545-1592). Acta Biomed 2022;93:e2022333. [PMID: 36533747 DOI: 10.23750/abm.v93i6.13599] [Reference Citation Analysis]
16 Wang HL, Lu WJ, Zhang YL, Nie CH, Zhou TY, Zhou GH, Zhu TY, Wang BQ, Chen SQ, Yu ZN, Jing L, Sun JH. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study. Front Med (Lausanne) 2021;8:737984. [PMID: 34671621 DOI: 10.3389/fmed.2021.737984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal Vein Thrombosis: Diagnosis and Endovascular Management. Rofo 2021. [PMID: 34649289 DOI: 10.1055/a-1642-0990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kotsifa E, Kykalos S, Machairas N, Nikiteas N, Sotiropoulos GC. Management of portal vein thrombosis in cirrhotic patients enlisted for liver transplantation: From diagnosis to treatment (Review). Biomed Rep 2021;15:94. [PMID: 34631049 DOI: 10.3892/br.2021.1470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shi Q, Xiong K, Ding B, Ye X. Clinical characteristics of cirrhosis patients with umbilical vein recanalization: A retrospective analysis. Medicine (Baltimore) 2021;100:e26774. [PMID: 34477116 DOI: 10.1097/MD.0000000000026774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Choi HH, Rodgers SK, Khurana A, Nelson LW, Kamaya A. Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance. Magn Reson Imaging Clin N Am 2021;29:279-90. [PMID: 34243917 DOI: 10.1016/j.mric.2021.05.005] [Reference Citation Analysis]
21 Toro-molina JL. Trombosis venosa portal en la cirrosis hepática. Hepatología 2021. [DOI: 10.52784/27112330.139] [Reference Citation Analysis]
22 Zhuravel SV, Aleksandrova VE, Kuznetsova NK, Novruzbekov MS, Donova LV. Protein C in a patient with portal vein thrombosis in liver transplantation. Transplantologiâ (Mosk ) 2021;13:151-157. [DOI: 10.23873/2074-0506-2021-13-2-151-157] [Reference Citation Analysis]
23 Huang L, Yu Q, Peng H. Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy. Med Sci Monit 2021;27:e931157. [PMID: 34120137 DOI: 10.12659/MSM.931157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 He Y, Yuan S, Guo X, Yi F, Xu X, An Y, Xu S, Ageno W, Qi X. Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis. BMC Gastroenterol 2021;21:253. [PMID: 34098892 DOI: 10.1186/s12876-021-01832-3] [Reference Citation Analysis]
25 He Y, Yuan S, Guo X, Yi F, Xu X, An Y, Xu S, Ageno W, Qi X. Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis. BMC Gastroenterol 2021;21:253. [PMID: 34098892 DOI: 10.1186/s12876-021-01832-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Chen H, Lei J, Liang S, Luo G, Deng M, Lü M. Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis. Can J Gastroenterol Hepatol 2021;2021:8859602. [PMID: 34007837 DOI: 10.1155/2021/8859602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Xian J, Tang Y, Shao H, Wang X, Zhang M, Xing T. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25439. [PMID: 33879676 DOI: 10.1097/MD.0000000000025439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Chatelin S, Pop R, Giraudeau C, Ambarki K, Jin N, Séverac F, Breton E, Vappou J. Influence of portal vein occlusion on portal flow and liver elasticity in an animal model. NMR Biomed 2021;34:e4498. [PMID: 33634498 DOI: 10.1002/nbm.4498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Güler E, Öztürk E, Yüksel M, Köse T, Harman M, Özütemiz A, Elmas N. Malign ile benign portal ven trombozunun ayrımında 3 Tesla manyetik rezonans görüntülemede difüzyon ağırlıklı görüntülemenin rolü. Akademik Gastroenteroloji Dergisi 2020. [DOI: 10.17941/agd.839289] [Reference Citation Analysis]
30 Bert J, Geerts A, Vanlander A, Abreu de Carvalho L, Degroote H, Berrevoet F, Rogiers X, van Vlierberghe H, Verhelst X. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation. Clin Transplant 2020;34:e14107. [PMID: 33030231 DOI: 10.1111/ctr.14107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Luzina EV, Tomina EA, Shchadneva SI, Lareva NV. Portal vein thrombosis — a literature review and our own clinical observations. jour 2020. [DOI: 10.31146/1682-8658-ecg-181-9-55-62] [Reference Citation Analysis]
32 Ma JL, He LL, Li P, Jiang L, Wei HS. Prognosis of endotherapy versus splenectomy and devascularization for variceal bleeding in patients with hepatitis B-related cirrhosis. Surg Endosc 2021;35:2620-8. [PMID: 32504262 DOI: 10.1007/s00464-020-07682-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kuriyama N, Kazuaki G, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Tanemura A, Kishiwada M, Sakurai H, Isaji S, Mizuno S. Surgical Procedures of Portal Vein Reconstruction for Recipients With Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation. Transplant Proc 2020;52:1802-6. [PMID: 32448668 DOI: 10.1016/j.transproceed.2020.01.155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Kaulitz R, Sieverding L, Hofbeck M. Portal vein thrombosis in Fontan-associated liver disease. Cardiol Young 2020;30:883-5. [PMID: 32406357 DOI: 10.1017/S1047951120000992] [Reference Citation Analysis]
35 Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation. J Clin Med 2020;9:E1181. [PMID: 32326024 DOI: 10.3390/jcm9041181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
36 Wu VC, Chen SW, Chou AH, Wu M, Ting PC, Chang SH, Wang CY, Lin MS, Hung KC, Hsieh IC, Chu PH, Wu CS, Lin YS. Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study. Medicine (Baltimore) 2020;99:e19575. [PMID: 32195968 DOI: 10.1097/MD.0000000000019575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Wei Q, He Z, Wang K, Li C, Al Ameri A, Zheng S, Xu X. Prediction model based on blood urea nitrogen and the leukocyte count for intestinal necrosis in patients with portal vein system thrombosis: a retrospective study. Ann Transl Med 2020;8:326. [PMID: 32355770 DOI: 10.21037/atm.2020.02.108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Zhang L, Huan H, Tong H, Wei B, Wang Z, Liu C, Wu H. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study. Medicine (Baltimore) 2020;99:e18737. [PMID: 31914090 DOI: 10.1097/MD.0000000000018737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Iliescu L. Liver Ultrasonography. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_40] [Reference Citation Analysis]
40 Sasaki K, Mcvey JC, Firl DJ, Andreatos N, Moro A, Coromina Hernandez L, Matsushima H, Teresa DU, Fujiki M, Aucejo FN, Quintini C, Kwon CD, Eghtesad B, Miller CM, Hashimoto K. Sufficient hepatic artery flow compensates for poor portal vein flow after liver transplantation in patients with portal vein thrombosis. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Alzubaidi S, Patel I, Saini A, Knuttinen G, Naidu S, Kriegshuaser S, Albadawi H, Oklu R. Current concepts in portal vein thrombosis: etiology, clinical presentation and management. Abdom Radiol (NY) 2019;44:3453-62. [PMID: 31407054 DOI: 10.1007/s00261-019-02174-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
42 Gawande R, Jalaeian H, Niendorf E, Olgun D, Krystosek L, Rubin N, Spilseth B. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction. Eur J Radiol 2019;118:88-95. [PMID: 31439264 DOI: 10.1016/j.ejrad.2019.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
43 Cool J, Rosenblatt R, Kumar S, Lucero C, Fortune B, Crawford C, Jesudian A. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort. J Gastroenterol Hepatol 2019;34:1088-92. [PMID: 30307066 DOI: 10.1111/jgh.14501] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
44 Iliescu L, Toma L, Mercan-Stanciu A, Grumeza M, Ioanitescu S. Contrast-Enhanced Ultrasonography in the Diagnosis of Portal Vein Thrombosis: A Pictorial Review. Ultrasound Q. 2019;35:311-315. [PMID: 31083039 DOI: 10.1097/ruq.0000000000000451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Elkrief L, Valla D. Hepatic Venous Outflow Syndromes and Splanchnic Venous Thrombosis. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch42] [Reference Citation Analysis]
46 Couri T, Harmath C, Baker T, Pillai A. Acute portal vein thrombosis after liver transplant presenting with subtle ultrasound abnormalities: A case report and literature review. World J Hepatol 2019; 11(2): 234-241 [PMID: 30820273 DOI: 10.4254/wjh.v11.i2.234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Eshraghian A, Nikeghbalian S, Kazemi K, Mansoorian M, Shamsaeefar A, Eghlimi H, Gholami S, Salahi H, Malek‐hosseini SA. Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long‐term outcomes after liver transplantation. Int J Clin Pract 2018;73:e13309. [DOI: 10.1111/ijcp.13309] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
48 Al Saeed M, Al-jiffry B, Younes A, Badr S, Abdel-rahman T, Hatem M, El-meteini M. Risk factors, pattern of presentation, methods of diagnosis, and results of treatment of acute portal vein thrombosis: A multicenter study. Saudi J Health Sci 2019;8:182. [DOI: 10.4103/sjhs.sjhs_77_19] [Reference Citation Analysis]
49 Wahab MA, Shehta A, Elshoubary M, Salah T, Fathy O, Sultan A, Elghawalby AN, Ali M, Yassen AM, Elmorshedi M, Eldesoky M, Monier A, Said R. Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems. J Gastrointest Surg 2018;22:2055-2063. [DOI: 10.1007/s11605-018-3876-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Wang CY, Wei LQ, Niu HZ, Gao WQ, Wang T, Chen SJ. Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis. World J Gastroenterol 2018; 24(39): 4482-4488 [PMID: 30357003 DOI: 10.3748/wjg.v24.i39.4482] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
51 Xue S, Wang P, Han H, Chen G. Portal Vein Thrombosis in Liver Cirrhosis. Management of Chronic Liver Diseases - Recent Advances 2018. [DOI: 10.5772/intechopen.76295] [Reference Citation Analysis]
52 Riva N, Ageno W. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective. J Transl Int Med 2018;6:6-10. [PMID: 29607297 DOI: 10.2478/jtim-2018-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Young K, Wong R. Evaluation and management of acute and chronic portal vein thrombosis in patients with cirrhosis. Clin Liver Dis (Hoboken) 2017;10:152-6. [PMID: 30992777 DOI: 10.1002/cld.679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
54 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
55 Tatum JM, Ley EJ. Cirrhosis and End-Stage Liver Disease. Surgical Critical Care Therapy 2018. [DOI: 10.1007/978-3-319-71712-8_51] [Reference Citation Analysis]
56 Zakko A, T Kroner P, Nankani R, Karagozian R. Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients. Gastroenterol Hepatol Bed Bench 2018;11:153-8. [PMID: 29910857] [Reference Citation Analysis]
57 Saeian K, Kohli A, Ahn J. Portal Hypertensive Gastrointestinal Bleeding. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_10] [Reference Citation Analysis]
58 Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Méndez-Sánchez N. Effects of Portal Vein Thrombosis on the Outcomes of Liver Cirrhosis: A Mexican Perspective. J Transl Int Med 2017;5:189-91. [PMID: 29340273 DOI: 10.1515/jtim-2017-0031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Takayesu JSK, Tringale KR, Marshall DC, Burkeen J, Valasek MA, Hemming A, Atwood T, Simpson D, Hattangadi-Gluth J. Bullet fragment fiducials in stereotactic body radiotherapy as a bridge to transplant for hepatocellular carcinoma. Acta Oncol 2017;56:1324-7. [PMID: 28497999 DOI: 10.1080/0284186X.2017.1324208] [Reference Citation Analysis]
60 Reinisch A. In Reply. Deutsches Ärzteblatt international 2017. [DOI: 10.3238/arztebl.2017.0613b] [Reference Citation Analysis]
61 Bezinover D, Reeder E, Aziz F, Saner F, McQuillan P, Kadry Z, Riley T, Guvakov D, Janicki PK. African Americans have a lower prevalence of portal vein thrombosis at the time of liver transplantation. HPB (Oxford) 2017;19:620-8. [PMID: 28495438 DOI: 10.1016/j.hpb.2017.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
62 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
63 Gulamhusein AF, Kamath PS. The epidemiology and pathogenesis of gastrointestinal varices. Techniques in Gastrointestinal Endoscopy 2017;19:62-8. [DOI: 10.1016/j.tgie.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
64 Yue-Meng W, Li YH, Wu HM, Yang J, Yang LH, Xu Y. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes. Clin Appl Thromb Hemost 2018;24:462-70. [PMID: 28110540 DOI: 10.1177/1076029616689593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
65 Zhang J, Wang Y, Gong J, Zhang F, Zhao Y. Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis. The American Surgeon 2016;82:1169-77. [DOI: 10.1177/000313481608201222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
66 Gudowska M, Wrona A, Gruszewska E, Panasiuk A, Cylwik B, Swiderska M, Filisiak R, Szmitkowski M, Chrostek L. Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases. Clin Exp Hepatol 2016;2:149-54. [PMID: 28856280 DOI: 10.5114/ceh.2016.63872] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Takano M, Kokudo T, Miyazaki Y, Kageyama Y, Takahashi A, Amikura K, Sakamoto H. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma. World J Gastroenterol 2016; 22(42): 9445-9450 [PMID: 27895433 DOI: 10.3748/wjg.v22.i42.9445] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Xue S, Zhang Q, Liu J, Wang PS, Chen G. Diagnosis and treatment of portal vein thrombosis after splenectomy and gastroesophageal devascularization. Shijie Huaren Xiaohua Zazhi 2016; 24(29): 4063-4069 [DOI: 10.11569/wcjd.v24.i29.4063] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Sarin SK, Philips CA, Kamath PS, Choudhury A, Maruyama H, Nery FG, Valla DC. Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis. Gastroenterology 2016;151:574-577.e3. [PMID: 27575821 DOI: 10.1053/j.gastro.2016.08.033] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 12.3] [Reference Citation Analysis]
70 Shim M, Yang TY, Cho NG, Woo A, Kim E, Park K, Lee JH, Lee YB, Hwang SG, Rim KS, Park H. Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus. Korean J Gastroenterol 2016;68:156-60. [PMID: 27646586 DOI: 10.4166/kjg.2016.68.3.156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Flanagan E, Ghaderi I, Overby DW, Farrell TM. Reduced Survival in Bariatric Surgery Candidates Delayed or Denied by Lack of Insurance Approval. The American Surgeon 2016;82:166-70. [DOI: 10.1177/000313481608200222] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
72 Li S, Zhang GX, Shang D. Portal venous system thrombosis complicating acute pancreatitis. Shijie Huaren Xiaohua Zazhi 2015; 23(28): 4529-4535 [DOI: 10.11569/wcjd.v23.i28.4529] [Reference Citation Analysis]
73 Chu H, Han W, Wang L, Xu Y, Jian F, Zhang W, Wang T, Zhao J. Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients. BMC Surg. 2015;15:89. [PMID: 26205377 DOI: 10.1186/s12893-015-0077-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]